Lemborexant: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 April 2025

  • curprev 13:3513:35, 13 April 2025 Omid Afkhami-Ardakani talk contribs 5,310 bytes +5,310 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Lemborexant |aOrAn=a |drugClass=Dual Orexin Receptor Antagonist (DORA)​ |indicationType=treatment |indication=adult patients with insomnia |adverseReactions=Somnolence​, Fatigue​, Headache​, Abnormal dreams​, Sleep paralysis​, and Hypnagogic hallucinations. |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition..."